Organization and disorganization of actin filaments in human epidermal keratinocytes: heat-shock treatment and recovery process.
We investigated alterations of actin organization due to heat shock and recovery from the collapse in human epidermal keratinocytes. Exposure of keratinocytes to elevated temperature caused the rapid disintegration of actin filaments. With a heat-shock treatment at 45 degrees C for 10 min, actin filaments disappeared and granular actin was distributed diffusely in the cytoplasm. After return to 37 degrees C, recovery of actin organization was observed. Completely disintegrated granular actin assembled to form actin dots, which tended to group. The grouping actin dots often took a circular, semicircular or arched form. Filamentous actin then extended out from the actin dots. Fine short bundles of actin filaments had a rippled appearance or were polygonal in structure, with actin filaments converged at many points. On the seventh day after heat-shock treatment, actin organization had almost returned to the pre-heat-shock condition, with diffusely distributed actin filaments. In previous studies, we observed such aberrant structures in human malignant keratinocytes and human epidermal keratinocytes treated with 12-O-tetradecanoylphorbol-13-acetate. The observations presented here indicate that those structures are not specific to malignancy or to the process of malignant transformation, but represent less mature and aberrant organizations of actin.
Kitano
Y
Y
Department of Dermatology, Hyogo College of Medicine, Japan.
Okada
N
N
D008841:Actin Cytoskeleton / Q000378:metabolism / Q000648:ultrastructure*; D000199:Actins / Q000378:metabolism*; D001151:Arsenic / Q000494:pharmacology; D018053:Arsenites; D003599:Cytoskeleton / Q000648:ultrastructure*; D000078404:Epidermal Cells; D005786:Gene Expression Regulation; D006360:Heat-Shock Proteins / Q000096:biosynthesis* / Q000235:genetics; D006358:Hot Temperature; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000648:ultrastructure*; D012878:Skin Neoplasms / Q000473:pathology; D017670:Sodium Compounds; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000199:Actins; D018053:Arsenites; D006360:Heat-Shock Proteins; D017670:Sodium Compounds; C017947:sodium arsenite; D001151:Arsenic; D013755:Tetradecanoylphorbol Acetate